Nov. 2018 @CMSGov exacerbated underdiagnosis of Medicare patients with #HBOC conflating germline and somatic tumor testing, restricting germline testing to patients with advanced cancer. Germline≠Somatic genetic testing. #Genetics #breastcancer @Invitae ht
Medicare patients with breast cancer are underdiagnosed for HBOC due to guidelines limiting access to germline genetic testing, and missing almost half of Medicare patients with genetic cancer risk. @Invitae #Genetics #genetictesting #breastcancer https://
RT @itrisabel: Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark | Spring…
Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark | SpringerLink @ClinicaNavarra @ESSOnews need to start thinking about changing the selection of patients for genetic testing https://t.c
RT @HenryKuerer: More data: https://t.co/4rb1K185DJ
RT @HenryKuerer: More data: https://t.co/4rb1K185DJ
More data: https://t.co/4rb1K185DJ
RT @annepeledmd: Just came across this study published in @AnnSurgOncol showing current #genetictesting guidelines for #breastcancer patien…
RT @annepeledmd: Just came across this study published in @AnnSurgOncol showing current #genetictesting guidelines for #breastcancer patien…
Just came across this study published in @AnnSurgOncol showing current #genetictesting guidelines for #breastcancer patients potentially miss many positive results #bcsm #hereditary cancer https://t.co/kiRgoGkUd9 https://t.co/246McTVnoR
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
Also, previous study of 1000 #breastcancer pts divided into 500 not meeting guidelines and 500 who did, showed no difference in mutation rate by 83 gene panel. Consumers can buy affordable $200 kits from radio. Little downside to testing now. @SocSurgOnc
Such an important finding!!
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
RT SocSurgOnc RT AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.https://t.co/LLWzUOEFZk McMastersKelly SocSurgOnc https://t.co/u8NcS14D39
RT @AnnSurgOncol: OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the…
OCTOER ISSUE: Underdiagnosis of #HereditaryBreastandOvarianCancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.https://t.co/e0Q8otTYiQ @McMastersKelly @SocSurgOnc https://t.co/4apwylHQqs
"a substantial number of Medicare patients with clinically actionable genetic variants are being missed by current testing criteria and suggest the need for significant expansion and simplification of the testing criteria for HBOC." https://t.co/7Uj3lywRZX
Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark. https://t.co/5sAVexqTnu